Wai Yuen Tong Medicine Holdings Ltd. provided unaudited consolidated earnings guidance for the six months ended September 30, 2013. The company expects the unaudited consolidated profit attributable to owners of the parent for the six months ended September 30, 2013 to record a significant increase as compared with that for the six months ended September 30, 2012. This expected significant profit increase is primarily attributable to, among other things, the increase in gross profit resulting from the increase in the Group's turnover, the gain from change in fair value of investments held-for-trading and the decrease in fair value gains on investment properties for the six months ended 30 September 2013 as compared with the corresponding period in 2012.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.224 HKD | +0.90% | -0.44% | -44.00% |
1st Jan change | Capi. | |
---|---|---|
-44.00% | 31.98M | |
+42.07% | 6.23B | |
-21.20% | 4.19B | |
+5.38% | 3.32B | |
-16.98% | 2.91B | |
-5.82% | 2.42B | |
+45.47% | 1.94B | |
-12.67% | 1.59B | |
-3.91% | 1.58B | |
+44.56% | 1.49B |
- Stock Market
- Equities
- 897 Stock
- News Wai Yuen Tong Medicine Holdings Limited
- Wai Yuen Tong Medicine Holdings Ltd. Provides Earnings Guidance for the Six Months Ended September 30, 2013